Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed.

Matthew Burman, Vladyslav Nikolayevskyy, Irina Kontsevaya, Barbara Molina-Moya, Olena Rzhepishevska, Lorenzo Guglielmetti
Author Information
  1. Matthew Burman: Centre for Primary Care and Public Health, Queen Mary University of London,London,UK.
  2. Vladyslav Nikolayevskyy: Public Health England, National Mycobacterium Reference Service South, London, UK.
  3. Irina Kontsevaya: Department of Medicine, Infectious Diseases and Immunity, Imperial College London, London, UK.
  4. Barbara Molina-Moya: Institut Germans Trias i Pujol (IGTP),Universitat Autònoma de Barcelona, Barcelona,Spain.
  5. Olena Rzhepishevska: Department of Chemistry,Umeå University, Umeå, Sweden.
  6. Lorenzo Guglielmetti: Centre Hospitalier de Bligny, Briis-sous-Forges, France.

Abstract

No abstract text available.

MeSH Term

Antitubercular Agents
Epidemics
Humans
Tuberculosis, Multidrug-Resistant
Ukraine

Chemicals

Antitubercular Agents